A regional survey of multiple sclerosis
prevalence (all categories included) of 72 per 100 000. Retrospective review of the history and medical records identified a poorer prognosis for disability where there was progressive onset of symptoms, secondary progression after a remitting phase, older age of onset (40 years or more), or a motor syndrome involving the limbs at presentation. In 1983 follow up data were obtained on 96 patients who were seen during a previous survey in 1968. For those with definite or probable MS, progression to severe disability (Kurtzke disability status scale (DSS) [6] [7] [8] [9] or death (DSS 10) was seen in 26134 with moderate disability (DSS [3] [4] [5] in 1968 and in only 5/29 with mild disability (DSS 0-2). When the analysis is confined to those with symptoms for at least five years in 1968, severe disability or death from MS occurred in 22130 with moderate and 4/19 with mild disability (j2 = 10.8, p = 0.001).
It is concluded that the patient's established disability level after five years of illness is a useful, but not infallible, prognostic indicator. From the follow up of the 1968 patients, the probability of MSrelated mortality for a given disease duration was calculated. Using this survival distribution to adjust the disability ratings in the 1983 population, it was -found that the proportion with mild disability decreased steadily with increasing disease duration, reaching 14% when the disease duration was more than 25 years.
There have been numerous studies of the natural history of multiple sclerosis (MS). We had three principal reasons for undertaking the present one.
First, no previous natural history study had been performed in New Zealand. Whilst there is no reason to think that the clinical characteristics differ from those encountered elsewhere, this had yet to be demonstrated. Data on natural history is of immediate relevance to those involved in advising patients regarding prognosis and in evaluating the effects of therapy.
Secondly, we were in a position to obtain long term follow up data on patients who had been seen in the same region by one of the authors 15 years earlier. ' Thirdly, we felt there was a good opportunity for relatively complete case ascertainment, the failure to achieve this introducing an important bias in many previous studies. *clinically definite or probable MS. ** these are the adjusted proportions, after the addition to the severe disability group of the estimated number of MS-related deaths for a given disease duration (based on the mortality rates calculated in the longitudinal study).
26-8% moderate and 26&8% severe disability.
The proportions with severe disability were very low in those with not more than five years of illness (2%, table 2), increasing sharply to 28% in those with disease of duration six to 10 years. Thereafter, there was a steady but small increase in the proportions with severe disability with increasing disease duration, reaching 39% with duration more than 25 years. Mild disability was present in 35% with disease duration 16-20 years, in 30% with duration 21-25 years, and in 26% with duration more than 25 years.
However, these proportions, being derived from a cross-sectional study, do not take account of patients who have already died from MS. To adjust for this, we used the life table of MS-related mortality versus disease duration calculated from the longitudinal study (see methods; results section B). Using this adjustment, the estimated proportions with mild disability are 32% at 16-20 years disease duration, falling to 23% at 21-25 years, and only 14% after more than 25 years. Conversely, severe disability or death from MS is calculated to occur in 39% after 16-20 years, 52% after 20-25 years, and 66% after more than 25 years. Eleven (5 3%) patients had a gradually progressive onset of symptoms (primary progressive MS) and there was significantly more disability in these patients (73% had severe disability, p < 0 0001 adjusted for disease duration). The remainder had an acute or subacute onset of symptoms typically with subsequent remission to some degree, although occasionally with a persistent stable deficit. At the time of assessment, secondary progression had developed in 63 (30-1%), while 135 (64 6%) were still in the relapsingremitting phase. The development of secondary progressive disease was associated with greater disability-68% had severe disability, compared with only 4% of those still in the relapsing-remitting phase (p < 0 000 1 adjusted for disease duration).
Among those whose onset of symptoms was at or above the age of 40, there was significantly more disability (p = 0'003 adjusted for disease duration; table 3). There was a nonsignificant trend towards more disability in males (p = 0-16).
There was significantly more disability in those who presented with a motor syndrome involving the limbs, either in isolation or in conjunction with sensory disturbances (table 4). Although only small numbers presented with a cerebral hemisphere or cerebellar disorder, 4 of 7 in the former category and 3 of 5 in the latter, had severe disability on prevalence day. Severe disability was present in a smaller proportion of those whose first symptoms were optic neuritis or sensory disturbance in the limbs, but the difference was not statistically significant.
The number of relapses in the first three years of illness did not have a significant effect on the long term course when comparing three groups-those with 0, 1, or greater than 1 relapses (p = 0-20 adjusted for disease duration). (TABLE 7) The analysis is again confined to patients who had definite or probable MS either in both 
Discussion
Weinshenker and Ebers2 have reviewed methodological difficulties which arise in studies of the natural history of MS. These include the difficulty in recruiting patients from onset of the illness; the frequent lack of longitudinal follow up data over a duration appropriate to the disease evolution; bias towards unusual or severe cases in tertiary centres; loss of institutionalised patients to follow up; and uncertainty as to the best parameter to measure outcome.
For a number of reasons, we feel that the present cross-sectional study was successful in detecting a high proportion of MS cases living inWellington in 1983. First, one of the authors (RWH) had been seeing a large cohort of MS patients within the region for over 20 years, and had undertaken a prevalence study 15 years earlier. Secondly, there was excellent cooperation in the referral of cases by the five neurologists who practised in the region at the time of the study. Thirdly, there was a single regional neurological service at Wellington Hospital, and it would be exceptional for patients to have gone outside of the region for their primary neurological assessment. Fourthly, community visits were undertaken to patients who were unable or unwilling to come to the clinic for the study.
Most findings in our cross-sectional study accord well with other studies. The sex ratios, ages of onset and patterns of clinical presentation are very typical. Rather a small percentage of our patients had primary progressive disease (5 3%; 95% confidence intervals (CI) 2-8-9-5%) -other studies have reported this onset in 8-33%.. 9-11 We often found that, on carefully reviewing the medical files or taking the history, there had been a transient episode of neurological disturbance, with remission, before progressive deterioration.
A little over one third of our patients in the cross-sectional study had a favourable course with minimal disability after 15-20 years, similar to the findings of McAlpine,'2 and of Poser et al 3 in a community group. Even after more than 25 years of illness, about onequarter of our patients had mild disability. However, the lack of a substantial change in the proportions with mild or severe disability after about 15 years is misleading, because as already discussed, deaths due to MS were not recorded in this cross-sectional study-the same limitation applies in other cross sectional studies. As we see from the longitudinal study, death from the disease was not uncommon over a 15 year period once there was an established moderate or severe disability. We thus made an adjustment for MS-related deaths based on the longitudinal study mortality data. Applying this adjustmnent, it was estimated that there would still be about onethird of patients with mild disability after 15-20 years, although this proportion fell to about one-seventh after more than 25 years of illness.
In the literature, a variety of factors has been associated with the subsequent prognosis for disability, some more consistently than others.
McAlpine"2 reported a worse outcome in those with lower limb weakness or cerebellar signs at presentation, and a better outcome if the presentation was optic neuritis, or a brainstem or posterior column disturbance. Confravreux et al' found greater disability where there was a short interval between the first two relapses, with an older age of onset and with development of progressive deterioration. Poser et al14 recorded a more favourable outcome when the onset was at a younger age, with optic neuritis as the presenting feature, and where the disease followed a remitting course. Visscher et al 5 identified a poorer outcome with older age of onset, motor weakness (without sensory disturbance), and impaired co-ordination. Thompson et al'6 established a better outlook where there was a younger age of onset, and a long interval of the first remission; the outlook was worse where there was limb weakness at onset or progressive disease. Finally; Phadke"l reported a shorter survival period in those with severe disability at a point in time, a cerebellar disturbance at onset, a short first remission, a primary or secondary progressive course, and an older age of onset. The factors which in our cross-sectional study were found to influence the subsequent course of the disease (progressive onset or secondary progression, a motor syndrome at onset, age of onset), have thus been noted previously.
The longitudinal study is of interest in providing prospective clinical information over an unusually long period (15 years). Although longitudinal follow up was possible only in the cohort with preserved 1968 records, the major demographic features in this cohort were similar to those found in the whole 1983 MS population, at which time ascertainment was relatively complete. Thus, we consider the longitudinal group to be reasonably representative of the general MS population.
Kurtzke et al 7 followed up a group of US veterans with MS. He found that of those with mild disability after five years (DSS 0-2), only 7 5% and 11A4% had developed severe disability after 10 and 15 years of disease respectively. Conversely, of those with moderate disability (DSS 3-5) after five years, 50% remained unchanged and 50% had become severely disabled or died from MS by 15 years.
TIhe findings of this study are very similarof those who in 1968 had MS for five or more years with mild disability, only 21% (95% CI 6-46%) had developed severe disability 15 years later. On the other hand, if moderate disability was present after at least five years of illness in 1968, over the next 15 years, 73% (95% CI 54-88%) developed severe disability or died from MS. Similar outcomes were observed in patients with mild or moderate disability who had had symptoms for less than five years in 1968; however, because there were only 17 patients in this group, it would be unwise to draw firm conclusions from this result.
While the difference in outcome between those with mild and moderate disability after five years of illness is highly significant, it should be noted that 5 patients with mild disability in 1968 were lost to follow up compared with only one with moderate disability. However, even if these 5 had all developed severe disability by 1983, the difference between the groups would still be significant (9/24 vs 22/30, p = 0-02). If, on the other hand, none of the five had become disabled, the difference between the groups would be even greater (4/24 vs 22/30, p = 0 0002). Therefore, we think that the difference in prognosis between the two groups is real. The more complete follow up of the more severely disabled groups probably reflects the loss of mobility of such individuals, and their greater need to stay under medical observation.
Among the patients who were followed longitudinally, the overall annual mortality rate was 3 0%, which accords fairly well with other studies which have reported rates varying from 1-3 to 4%.1>20 We found that 66% (95% CI 47-81 %) of deaths were MS-related, similar to the figure of 62% reported in a much larger study." Phadke" also found a much lower probability of survival over a 10 year period in patients with severe disability, and our own observations concur with this. The survival curve in our MS patients is similar to that reported recently by Poser et al.2"
What can we derive from the present and other natural history studies of MS for counselling our patients at time of diagnosis? First, it can be said that a sizable proportion of patients (about a third) will be free of significant disability after about 15 years; however, after a longer period (more than 25 years), this proportion is smaller-perhaps about oneseventh. Secondly, a moderately optimistic prognosis can be given to the younger patient (age less than 40 years), whose initial episode was optic neuritis or an isolated sensory disturbance of spinal cord origin. The outlook is generally worse for those with older age of onset, motor or cerebellar features at presentation, or progressive onset of disease. Thirdly, the present study and that of Kurtzke et al, '7 suggest that the clinical disability after five years of illness is perhaps the most reliable predictor of long term outcome that is currently available. It must be recognised, however, that predictions are never certain in any individual case.
Neurological stamp
Johanne Weyer (Wier) Weyer, a Dutch physician and surgeon opposed the persecution of witches. He did not accept that humans could be transformed into animals and that witches flew through the air on broomsticks. He maintained that witches were merely people who had lost control of their emotions, and their minds had become distorted with hallucinations.
At the time belief in witches was widespread. The inquisitors Sprenger and Kramer published their infamous Malleus Maleficarum in 1485, a penal code that regulated the punishment of those who practiced witchcraft. As a result countless patients with psychiatric disorders were tortured and burnt. The 
